These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36511872)

  • 1. G-rich motifs within phosphorothioate-based antisense oligonucleotides (ASOs) drive activation of FXN expression through indirect effects.
    Wang F; Calvo-Roitberg E; Rembetsy-Brown JM; Fang M; Sousa J; Kartje ZJ; Krishnamurthy PM; Lee J; Green MR; Pai AA; Watts JK
    Nucleic Acids Res; 2022 Dec; 50(22):12657-12673. PubMed ID: 36511872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Frataxin Protein Expression by Antisense Oligonucleotides Targeting the Mutant Expanded Repeat.
    Li L; Shen X; Liu Z; Norrbom M; Prakash TP; O'Reilly D; Sharma VK; Damha MJ; Watts JK; Rigo F; Corey DR
    Nucleic Acid Ther; 2018 Feb; 28(1):23-33. PubMed ID: 29341839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting 3' and 5' untranslated regions with antisense oligonucleotides to stabilize frataxin mRNA and increase protein expression.
    Li Y; Li J; Wang J; Lynch DR; Shen X; Corey DR; Parekh D; Bhat B; Woo C; Cherry JJ; Napierala JS; Napierala M
    Nucleic Acids Res; 2021 Nov; 49(20):11560-11574. PubMed ID: 34718736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress towards drug discovery for Friedreich's Ataxia: Identifying synthetic oligonucleotides that more potently activate expression of human frataxin protein.
    Shen X; Wong J; Prakash TP; Rigo F; Li Y; Napierala M; Corey DR
    Bioorg Med Chem; 2020 Jun; 28(11):115472. PubMed ID: 32279920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating frataxin expression by single-stranded siRNAs targeting the GAA repeat expansion.
    Shen X; Kilikevicius A; O'Reilly D; Prakash TP; Damha MJ; Rigo F; Corey DR
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2850-2855. PubMed ID: 30076049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice.
    Kilikevicius A; Wang J; Shen X; Rigo F; Prakash TP; Napierala M; Corey DR
    RNA Biol; 2022; 19(1):364-372. PubMed ID: 35289725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient electroporation of neuronal cells using synthetic oligonucleotides: identifying duplex RNA and antisense oligonucleotide activators of human frataxin expression.
    Shen X; Beasley S; Putman JN; Li Y; Prakash TP; Rigo F; Napierala M; Corey DR
    RNA; 2019 Sep; 25(9):1118-1129. PubMed ID: 31151992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature transcription termination at the expanded GAA repeats and aberrant alternative polyadenylation contributes to the Frataxin transcriptional deficit in Friedreich's ataxia.
    Li Y; Li J; Wang J; Zhang S; Giles K; Prakash TP; Rigo F; Napierala JS; Napierala M
    Hum Mol Genet; 2022 Oct; 31(20):3539-3557. PubMed ID: 35708503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich's Ataxia Patients.
    Misiorek JO; Schreiber AM; Urbanek-Trzeciak MO; Jazurek-Ciesiołka M; Hauser LA; Lynch DR; Napierala JS; Napierala M
    Mol Neurobiol; 2020 Jun; 57(6):2639-2653. PubMed ID: 32291635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells.
    Vilema-Enríquez G; Quinlan R; Kilfeather P; Mazzone R; Saqlain S; Del Molino Del Barrio I; Donato A; Corda G; Li F; Vedadi M; Németh AH; Brennan PE; Wade-Martins R
    J Biol Chem; 2020 Dec; 295(52):17973-17985. PubMed ID: 33028632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A GAA repeat expansion reporter model of Friedreich's ataxia recapitulates the genomic context and allows rapid screening of therapeutic compounds.
    Lufino MM; Silva AM; Németh AH; Alegre-Abarrategui J; Russell AJ; Wade-Martins R
    Hum Mol Genet; 2013 Dec; 22(25):5173-87. PubMed ID: 23943791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SINEUP non-coding RNAs rescue defective frataxin expression and activity in a cellular model of Friedreich's Ataxia.
    Bon C; Luffarelli R; Russo R; Fortuni S; Pierattini B; Santulli C; Fimiani C; Persichetti F; Cotella D; Mallamaci A; Santoro C; Carninci P; Espinoza S; Testi R; Zucchelli S; Condò I; Gustincich S
    Nucleic Acids Res; 2019 Nov; 47(20):10728-10743. PubMed ID: 31584077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating frataxin expression by repeat-targeted nucleic acids.
    Li L; Matsui M; Corey DR
    Nat Commun; 2016 Feb; 7():10606. PubMed ID: 26842135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.
    Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygosity for an expanded (GAA) and a (GAAGGA) repeat at FXN locus: from a diagnostic pitfall to potential clues to the pathogenesis of Friedreich ataxia.
    Santoro M; Perna A; La Rosa P; Petrillo S; Piemonte F; Rossi S; Riso V; Nicoletti TF; Modoni A; Pomponi MG; Chiurazzi P; Silvestri G
    Neurogenetics; 2020 Oct; 21(4):279-287. PubMed ID: 32638185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
    Anjomani Virmouni S; Ezzatizadeh V; Sandi C; Sandi M; Al-Mahdawi S; Chutake Y; Pook MA
    Dis Model Mech; 2015 Mar; 8(3):225-35. PubMed ID: 25681319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich's ataxia.
    Kim E; Napierala M; Dent SY
    Nucleic Acids Res; 2011 Oct; 39(19):8366-77. PubMed ID: 21745819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human frataxin is regulated by transcription factors SRF and TFAP2.
    Li K; Singh A; Crooks DR; Dai X; Cong Z; Pan L; Ha D; Rouault TA
    PLoS One; 2010 Aug; 5(8):e12286. PubMed ID: 20808827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.
    Al-Mahdawi S; Pinto RM; Varshney D; Lawrence L; Lowrie MB; Hughes S; Webster Z; Blake J; Cooper JM; King R; Pook MA
    Genomics; 2006 Nov; 88(5):580-90. PubMed ID: 16919418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Friedreich's ataxia--a case of aberrant transcription termination?
    Butler JS; Napierala M
    Transcription; 2015; 6(2):33-6. PubMed ID: 25831023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.